Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gérald Simonneau

Showing results (1-10 of 303) with videos related to

Pageof 31
Sort By:
Presse Medicale (Paris, France : 1983)|August 25, 2010
[Introduction. Pulmonary arterial hypertension]Gérald Simonneau
La Revue Du Praticien|January 16, 2009
[Pulmonary hypertension. Major therapeutic advances]Gérald Simonneau
Bulletin De L'Academie Nationale De Medecine|July 31, 2010
[A new clinical classification of pulmonary hypertension]Gérald Simonneau
American Journal of Respiratory and Critical Care Medicine|December 23, 2017
Reply to Frachon: Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension: A Missing Chapter of the Story?Gérald Simonneau, Marc Humbert
American Journal of Respiratory and Critical Care Medicine|October 19, 2017
Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension. A New Chapter of the StoryGérald Simonneau, Marc Humbert
Current Opinion in Pulmonary Medicine|April 9, 2010
Perspective on the optimal endpoints for pulmonary arterial hypertension trialsLewis Rubin, Gérald Simonneau
European Respiratory Review : an Official Journal of the European Respiratory Society|December 3, 2013
The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertensionSean Gaine, Gérald Simonneau
Presse Medicale (Paris, France : 1983)|August 17, 2014
[Pulmonary hypertension: definition, diagnostic and new classification]Andrei Seferian, Gérald Simonneau
Presse Medicale (Paris, France : 1983)|February 10, 2010
[Eisenmenger syndrome. Role of rare diseases reference centers in the management of pulmonary hypertension in congenital heart diseases]Damien Bonnet, Gérald Simonneau
Nature Clinical Practice. Rheumatology|August 26, 2006
Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseasesMarc Humbert, Gérald Simonneau
Pageof 31

Showing results (1-10 of 303) with videos related to

Sort By:
Pageof 31
Presse Medicale (Paris, France : 1983)|August 25, 2010
[Introduction. Pulmonary arterial hypertension]Gérald Simonneau
La Revue Du Praticien|January 16, 2009
[Pulmonary hypertension. Major therapeutic advances]Gérald Simonneau
Bulletin De L'Academie Nationale De Medecine|July 31, 2010
[A new clinical classification of pulmonary hypertension]Gérald Simonneau
American Journal of Respiratory and Critical Care Medicine|December 23, 2017
Reply to Frachon: Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension: A Missing Chapter of the Story?Gérald Simonneau, Marc Humbert
American Journal of Respiratory and Critical Care Medicine|October 19, 2017
Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension. A New Chapter of the StoryGérald Simonneau, Marc Humbert
Current Opinion in Pulmonary Medicine|April 9, 2010
Perspective on the optimal endpoints for pulmonary arterial hypertension trialsLewis Rubin, Gérald Simonneau
European Respiratory Review : an Official Journal of the European Respiratory Society|December 3, 2013
The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertensionSean Gaine, Gérald Simonneau
Presse Medicale (Paris, France : 1983)|August 17, 2014
[Pulmonary hypertension: definition, diagnostic and new classification]Andrei Seferian, Gérald Simonneau
Presse Medicale (Paris, France : 1983)|February 10, 2010
[Eisenmenger syndrome. Role of rare diseases reference centers in the management of pulmonary hypertension in congenital heart diseases]Damien Bonnet, Gérald Simonneau
Nature Clinical Practice. Rheumatology|August 26, 2006
Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseasesMarc Humbert, Gérald Simonneau
Pageof 31